CLL has a distinct BCR signaling from normal B cells, which is characterized by a variable response to antigen stimulation, activation of anti-apoptotic signaling pathways and low IgM expression. This evidence concerns the gene CD40LG and B-cell chronic lymphocytic leukemia.